Key result
Overexpression of CuZnSOD in the OVLT significantly attenuated the increase in mean arterial pressure induced by 10 days of Angiotensin II infusion in rats (18 ± 5 mmHg vs 33 ± 8 mmHg).
Why the study?
Does overexpression of CuZnSOD in the OVLT attenuate Angiotensin II-induced hypertension in rats?
Does overexpression of CuZnSOD in the OVLT attenuate Angiotensin II-induced hypertension in rats?
Overexpression of the superoxide-scavenging enzyme CuZnSOD in the OVLT significantly attenuates chronic Angiotensin II-induced hypertension in rats, highlighting the role of central superoxide signaling in blood pressure regulation.
Angiotensin II (AngII) can access the brain via circumventricular organs (CVOs), including the subfornical organ (SFO) and organum vasculosum of the lamina terminalis (OVLT), to modulate blood pressure. Previous studies have demonstrated a role for both the SFO and OVLT in the hypertensive response to chronic AngII, yet it is unclear which intracellular signaling pathways are involved in this response. Overexpression of copper/zinc superoxide dismutase (CuZnSOD) in the SFO has been shown to attenuate the chronic hypertensive effects of AngII. Presently, we tested the hypothesis that elevated levels of superoxide (O2 (∙-)) in the OVLT contribute to the hypertensive effects of AngII. To facilitate overexpression of superoxide dismutase, adenoviral vectors encoding human CuZnSOD or control adenovirus (AdEmpty) were injected directly into the OVLT of rats. Following 3 days of control saline infusion, rats were intravenously infused with AngII (10 ng/kg/min) for ten days. Blood pressure increased 33 ± 8 mmHg in AdEmpty rats (n = 6), while rats overexpressing CuZnSOD (n = 8) in the OVLT demonstrated a blood pressure increase of only 18 ± 5 mmHg after 10 days of AngII infusion. These results support the hypothesis that overproduction of O2 (∙-) in the OVLT plays an important role in the development of chronic AngII-dependent hypertension.
No takes yet. Share an insight, caveat, or question.
Collister et al. (2016) studied Angiotensin II-induced hypertension (n=14). Adenoviral vectors encoding human CuZnSOD (AdCuZnSOD) injected into the OVLT vs. Control adenovirus (AdEmpty) was evaluated on Increase in mean arterial pressure (MAP) after 10 days of AngII infusion (p=<0.05). Overexpression of CuZnSOD in the OVLT significantly attenuated the increase in mean arterial pressure induced by 10 days of Angiotensin II infusion in rats (18 ± 5 mmHg vs 33 ± 8 mmHg).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: